Poging GOUD - Vrij

NPPA fixes revised prices of 6 scheduled formulations

Chronicle Pharmabiz

November 13, 2025

THE National Pharmaceutical Pricing Authority has fixed the ceiling price of six formulations under the revised Schedule I of DPCO 2013, including three strengths of human immunoglobulin, denatured ethyl alcohol, peritoneal dialysis solution, and vitamin tablet riboflavin.

- Gireesh Babu, New Delhi

The Authority considered company representations regarding fixation of revised prices for four formulations, and rejected during the process of finalising the ceiling prices.

Dit verhaal komt uit de November 13, 2025-editie van Chronicle Pharmabiz.

Abonneer u op Magzter GOLD voor toegang tot duizenden zorgvuldig samengestelde premiumverhalen en meer dan 9000 tijdschriften en kranten.

Bent u al abonnee? Aanmelden

MEER VERHALEN VAN Chronicle Pharmabiz

Bekijk alles

Chronicle Pharmabiz

Odisha govt convenes 'Pharma summit' on Nov 20 in Bhubaneswar

THE Government of Odisha has issued a comprehensive and robust invitation to investors from across the country to participate in the upcoming 'Odisha Pharma Summit' scheduled for November 20 in Bhubaneswar.

2 mins

November 13, 2025

Chronicle Pharmabiz

APPC announces election schedule to elect 6-member

THE office of the returning officer (RO) for the election of the Andhra Pradesh Pharmacy Council (APPC) has issued an official notice, dated November 2, 2025, detailing the schedule for the election of six members to the council.

1 mins

November 13, 2025

Chronicle Pharmabiz

NPPA fixes revised prices of 6 scheduled formulations

1 mins

November 13, 2025

Chronicle Pharmabiz

WHO launches guidance for health emergencies

THE World Health Organization (WHO) has released a comprehensive guide, the National Health Emergency Alert and Response Framework, to help countries strengthen their preparedness and response to health emergencies.

1 min

November 13, 2025

Chronicle Pharmabiz

AI, next-gen diagnostics offer new hope in India's cancer battle

HOSPITALS and pharma industry note that in India's battle against cancer, biomarkers, nextgen sequencing diagnostics and Al-based tools empower clinicians to identify risks earlier.

2 mins

November 13, 2025

Chronicle Pharmabiz

UK MHRA approves Serum Life Sciences' Siiltibcy

THE Medicines and Healthcare products Regulatory Agency (MHRA) has approved Siiltibcy (rdESAT-6 and rCFP-10), a diagnostic aid for detection of Mycobacterium tuberculosis infection, including tuberculosis disease, in adults and children.

1 min

November 13, 2025

Chronicle Pharmabiz

Biotech fostering innovation, ethical solutions to overcome challenges

GLOBAL and India's biotechnology industry plays a pivotal role in driving research, fostering innovation, and developing ethical solutions to address the complex challenges in drug development.

2 mins

November 13, 2025

Chronicle Pharmabiz

DGFT seeks feedback on application format for SCOMET export authorisation

THE Directorate General of Foreign Trade (DGFT) has invited comments and suggestions from exporters, industry associations, and other stakeholders on a proposed single-format application form for obtaining authorisation to export SCOMET items (Special Chemicals, Organisms, Materials, Equipment and Technologies).

1 mins

November 13, 2025

Chronicle Pharmabiz

AICDF launches campaign against illegal drug marketers

THE All India Chemists and Distributors Federation (AICDF) has launched a campaign to root out 'Black Sheep' marketing houses operating illegally and promoting unregistered brands across the country.

2 mins

November 13, 2025

Chronicle Pharmabiz

Haryana DCA cracks down on illegal drug sales

ACTING decisively under the ongoing Nasha Mukti Bharat Abhiyan' and explicit directions from FDA Commissioner Manoj Kumar, the drug control administration (DCA) in Haryana executed a major, coordinated inspection drive in Sirsa district on November 3.

1 mins

November 13, 2025